Jan 11, 2021 / 03:00PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst
Welcome, everyone. I'm Robbie Marcus, the Medtech analyst at JPMorgan. I'm happy to move to our next session, which is CONMED. I have the CEO, Curt Hartman, who's going to be presenting. And then we're going to be followed up in Q&A with Todd Garner, the CFO.
Just a few reminders for everyone in this virtual environment. You can go to the JPMorgan Healthcare Conference website and grab the slide deck to follow along at your own pace. (Operator Instructions)
So with that, Curt, take it away, and I will join you for Q&A afterwards.
Curt R. Hartman - CONMED Corporation - Chairman of the Board, CEO & President
Great. Thank you, Robbie, and good morning, everybody. And I do want to point out, Todd is here with me and he'll be joining in the Q&A. Hopefully, you've been able to access the presentation, and I'll try to keep cadence with you by calling out the page numbers as I go through them.
So first is Page 2, which is a reminder of our forward
Conmed Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot